Key facts
- It has raised $13.0M; the latest was Later Stage VC in Oct 2024.
- Notable investors include Wing Venture Capital, Primer Sazze Partners, Gradient (Korea), Big Basin Capital, First In Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for MEDIC Life Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for MEDIC Life Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MEDIC Life Sciences
Developer of a drug discovery platform designed to provide synergistic drug combinations for cancer treatment. The company's platform accurately captures tumor suppressor, and oncogene phenotypes and systematically installs variants that mimic cancer mutations to measure associations of drugs with all the mutations, enabling the healthcare industry to provide medicines that help treat tumors and other diseases.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2019
- Employees
- 8
- Website
- medic-life-sciences.com/
- Ownership
- Privately Held (backing)
MEDIC Life Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MEDIC Life Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MEDIC Life Sciences in its N-PORT filings yet. We sweep new filings monthly.